Rinda Sama - 11 Jun 2021 Form 4 Insider Report for Axonics, Inc.

Role: Chief Operating Officer
Signature: /s/ Dan Dearen, as Attorney-in-Fact for Rinda Sama
Issuer symbol: N/A
Transactions as of: 11 Jun 2021
Net transactions value: -$120,266
Form type: 4
Filing time: 16 Jun 2021, 20:53:18 UTC
Previous filing: 10 Jun 2021
Next filing: 03 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXNX	Common Stock	Options Exercise	$37,433	+2,638	+9.1%	$14.19^*	31,536	11 Jun 2021	Direct
transaction	AXNX	Common Stock	Sale	$157,700	-2,638	-8.4%	$59.78	28,898	11 Jun 2021	Direct	F1
holding	AXNX	Common Stock						4,000	11 Jun 2021	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXNX	Stock Option (Right to Buy)	Options Exercise	$0	-2,638	-6.7%	$0.000000	36,568	11 Jun 2021	Common Stock	2,638	$14.19	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2	The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on January 30th, 2020, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of January 30th, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.

Content

The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on January 30th, 2020, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of January 30th, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.